Curcumin “Drug” Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity
- 3 October 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 56 (20) , 12457-12468
Abstract
Ternary oxidovanadium(IV) complexes of curcumin (Hcur), dipicolylamine (dpa) base, and its derivatives having pendant noniodinated and di-iodinated boron-dipyrromethene (BODIPY) moiety (L1 and L2, respectively), namely, [VO(dpa)(cur)]ClO4 (1), [VO(L1)(cur)]ClO4 (2), and [VO(L2)(cur)]ClO4 (3) and their chloride salts (1a–3a) were prepared, characterized, and studied for anticancer activity. The chloride salts were used for biological studies due to their aqueous solubility. Complex 1 was structurally characterized by single-crystal X-ray crystallography. The complex has a VO2+ moiety bound to dpa ligand showing N,N,N-coordination in a facial mode, and curcumin is bound in its mono-anionic enolic form. The V–O(cur) distances are 1.950(18) and 1.977(16) Å, while the V–N bond lengths are 2.090(2), 2.130(2), and 2.290(2) Å. The bond trans to V═O is long due to trans effect. The complexes are stable in a solution phase over a long period of time of 48 h without showing any apparent degradation of the curcumin ligand. The diiodo-BODIPY ligand (L2) or Hcur alone showed limited solution stability in dark. The emissive BODIPY (L1) containing complex 2a showed preferential mitochondrial localization in MCF-7 cells in cellular imaging experiments. The cytotoxicity of the complexes was studied by MTT assay. The BODIPY complex 3a showed excellent photodynamic therapy effect in visible light (400–700 nm) giving IC50 values of 2–6 μM in HeLa and MCF-7 cancer cells, while being less toxic in dark (∼100 μM). The cell death was apoptotic in nature involving reactive oxygen species (ROS). Mechanistic data from pUC19 DNA photocleavage studies revealed photogenerated ROS as primarily 1O2 from the BODIPY moiety and ·OH radicals from the curcumin ligand.Keywords
Funding Information
- Indian Institute of Science
- Department of Biotechnology , Ministry of Science and Technology
- Department of Science and Technology, Ministry of Science and Technology (EMR/2015/000742, SR/S5/MBD-02/2007)
This publication has 65 references indexed in Scilit:
- Biological and therapeutic activities, and anticancer properties of curcuminExperimental and Therapeutic Medicine, 2015
- The Chemistry of Curcumin: From Extraction to Therapeutic AgentMolecules, 2014
- Curcumin Extract for Prevention of Type 2 DiabetesDiabetes Care, 2012
- Design, synthesis, synergistic antimicrobial activity and cytotoxicity of 4-aryl substituted 3,4-dihydropyrimidinones of curcuminBioorganic & Medicinal Chemistry Letters, 2012
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinomaMolecular Cancer, 2011
- Revisiting dietary antioxidants, neurodegeneration and dementiaNeuroReport, 2011
- Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical TrialsArchiv der Pharmazie, 2010
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends in Pharmacological Sciences, 2009
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe International Journal of Biochemistry & Cell Biology, 2009
- Curcumin: From ancient medicine to current clinical trialsCellular and Molecular Life Sciences, 2008